Skip to main content
SpringerLink
Log in

A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes

  • Original
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

This study discusses two main questions: the direct medical costs and the clinical effectiveness of the hospital treatment with insulin of pregnant women with gestational diabetes (GD). A prospective study that includes 50 women with GD is performed. The pregnant women are divided into 2 groups: Group I (n=30) — pregnant women treated only with a diet; and Group II (n=20) — pregnant women treated with diet and insulin. We found that the metabolite compensation degree is improved after the applied treatment with insulin. The coefficient cost/effectiveness is 6954 lv./100 women. The analysis decision tree confirms in a very convenient way the fact that insulin treatment is a clinically more effective and financially more profitable strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jovanovic L, Pettit DJ (2001) Contempo Updates: linking evidence and experience: gestational diabetes mellitus. JAMA 286:2516–2518

    Article  PubMed  CAS  Google Scholar 

  2. O’sullivan JB (1991) Diabetes mellitus after GDM. Diabetes 299[Suppl 2]:131–135

    Google Scholar 

  3. Hollingsworth DR, Cousins L (1984) Endocrine and metabolic disorders. In Creasy RK, Resnik E (eds) Maternal fetal medicine principles and practice. W.B. Saunders Co., pp 8333–8986

  4. Pallardo F, Herranz L, Garcia Ingelmo T, Grande C, Martin-Vaquero P, Janez M, Gonzalez A (1999) Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 22:1053–1058

    Article  PubMed  CAS  Google Scholar 

  5. American Diabetes Association (2000) Gestational diabetes mellitus. Diabetes Care 21[Suppl 1]:877–879

    Google Scholar 

  6. Introduction in the healthcare economics for the Eastern European countries and former USSR. In Wiley & Sons Ltd, 1997, ISBN-10:0471966630, pp 15–216

Download references

Author information

Authors and Affiliations

  1. Maternity Hospital “Maichin Dom”, Sofia, Bulgaria

    K. Todorova

  2. Department of Social Pharmacy Faculty of Pharmacy, Medical University, 2 Dunav St., BG-Sofia, 1000, Bulgaria

    O. Palaveev, V. B. Petkova, M. Stefanova & Zl. Dimitrova

Authors
  1. K. Todorova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Palaveev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. B. Petkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Stefanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zl. Dimitrova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. B. Petkova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Todorova, K., Palaveev, O., Petkova, V.B. et al. A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes. Acta Diabetol 44, 144–148 (2007). https://doi.org/10.1007/s00592-007-0255-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-007-0255-5

Key words

Search

Navigation